Skip to main content
Premium Trial:

Request an Annual Quote

Polyclone of India and Emphron of Australia to Jointly Provide Data Analysis, Experimental Design

NEW YORK, Aug. 19 (GenomeWeb News) - Polyclone Bioservices of Bangalore, India, and Emphron of Queensland, Australia, are teaming up to consult in data analysis, data mining, and experimental design for proteomics and genomics, Polyclone said yesterday.

 

The companies plan to combine Emphron's bioinformatics data-analysis capabilities and Polyclone's microarray core facility, which is being set up at the Universityof Agricultural Sciencesin Dharwar. The new facility will focus on developing new arrays and provide analysis tools to researchers.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.